These new solid-state ACs promise a cool future. Scientists aren’t so sure.
These new solid-state ACs promise a cool future. Scientists aren’t so sure.

After three years of record-­breaking heat, this one is set to be yet another scorcher. Air-conditioning? Not going anywhere. The International Energy Agency projects that the number of AC units will triple by 2050. That’s good for health—one Lancet study estimated that AC prevented nearly 200,000 premature deaths in 2019 alone—but bad for the planet.…

You do your own time

There we were, a regular murderers’ row of librarians. Little Jo. Eustace. And me. Turning around in the nave of our library to greet the sound of footsteps, pistols leveled in case whoever was coming in didn’t respect sanctuary. Little Jo had a stack of books under one arm. Eustace was holding the screwdriver she’d…

Inside Interoception: The hidden sense of how you feel inside

MIT Technology Review Explains: Let our writers untangle the complex, messy world of science and technology to help you understand what’s coming next. You can read more from the series here. Your brain lives in the dark space of your skull. Yet it knows when the wind lifts the hairs on your skin, when your heart is…

Why “reprogramming” is the buzziest approach to reversing aging right now
Why “reprogramming” is the buzziest approach to reversing aging right now

Earlier this week, Life Biosciences, a biotech company focused on reversing age-related diseases, announced that it had dosed its first volunteer. A person with glaucoma has had an experimental treatment injected straight into their eyeball. The idea is to try to treat the disease—which can cause vision loss—by regenerating healthy nerves in the eye. But…

Google DeepMind is worried about what happens when millions of agents start to interact

Google DeepMind is funding research into the potential dangers of millions of different AI agents interacting with each other online. According to Rohin Shah, who directs the company’s AGI safety and alignment research, the mass-market arrival of agents that can carry out tasks without human oversight and follow instructions given to them by other agents creates…

Why China is betting on big nuclear reactors

It’s a tale of two nuclear industries. In China, large reactors are coming together at a stunning pace. The country has nearly doubled its nuclear fleet since 2016, reaching nearly 60 gigawatts of total power capacity. The new facilities are nearly all gigawatt-scale pressurized-water reactors. Meanwhile, the US has built just two reactors in that…

Inside soccer’s data renaissance

Imagine tuning in to the opening kickoff of a World Cup match and seeing a player intentionally send the ball all the way down the pitch and right out of bounds on the opponent’s end. Casual fans might scratch their heads. Where’s the logic in surrendering possession seconds into a game? If you were Jesse…

Job titles of the future: Nature’s drug designer

In 2018, after nearly two decades working in Big Pharma, chemist Tim Cernak was ready to put his skills to a new use.  For Merck, he’d developed precision therapies for cancer, HIV, and diabetes that could target disease while minimizing harm to healthy cells. But as a lifelong nature lover, he was increasingly concerned about…

The “steroid olympics” were a circus—and a window into our culture
The “steroid olympics” were a circus—and a window into our culture

Testosterone. Methenolone. Nandrolone. Human growth hormone and EPO. Meldonium, modafinil, and mixed amphetamine salts. Clomiphene, anastrozole, levothyroxine, and liothyronine. Patches and capsules, creams and pills. A whole galaxy  of steroids, metabolic modulators, and synthetic hormones coursing through the blood of a few dozen swimmers, sprinters, and weightlifters. And millions of dollars up for grabs for…

David Sinclair plans to test whole-body rejuvenation drugs in the XPrize competition

The outspoken longevity scientist David Sinclair has been predicting that one day, you’ll go to the doctor and get a prescription that will make you 10 years younger. Now MIT Technology Review has learned that he has plans to launch human tests of an oral “reprogramming” drug as part of a $101 million competition organized…